Table 4 Indications for caesarean section in transfused versus non-transfused patients
From: Caesarean delivery-related blood transfusion: correlates in a tertiary hospital in Southwest Nigeria
Variable | Transfused (N = 188) | Not transfused (N = 718) | Crude Odds Ratio(cOR) | 95%CI | P value |
|---|---|---|---|---|---|
Repeat C/S | |||||
Yes | 22(20.8%) | 84(79.2%) | 1.0 | 0.61–1.64 | 0.99 |
No | 165(20.8%) | 628(79.2%) | 1.0 | Reference | Reference |
Cephalopelvic disproportion | |||||
Yes | 29(12.9%) | 195(87.1%) | 0.49 | 0.32–0.75 | <0.001 |
No | 158(23.4%) | 517(76.6%) | 1.0 | Reference | Reference |
Preeclampsia/Eclampsia | |||||
Yes | 64(30%) | 149(70.0%) | 0.26 | 1.38–2.80 | <0.001 |
No | 124(17.9%) | 569(82.1%) | 1.0 | Reference | Reference |
Placenta Previa | |||||
Yes | 51(81.0%) | 12(19.0%) | 21.88 | 11.36–42.11 | <0.001 |
No | 136(16.3%) | 700(83.7%) | 1.0 | Reference | Reference |
Abruptio Placenta | |||||
Yes | 46(82.1%) | 10(17.9%) | 22.94 | 11.31–46.52 | <0.001 |
No | 142(16.7%) | 708(83.3%) | 1.0 | Reference | Reference |
Non reassuring fetal status | |||||
Yes | 17(11.2%) | 135(88.8%) | 0.43 | 0.25–0.73 | 0.002 |
No | 171(22.7%) | 583(77.3%) | 1.0 | Reference | Reference |
Malpresentation | |||||
Yes | 11(6.9%) | 148(93.1%) | 0.24 | 0.13–0.45 | <0.001 |
No | 177(23.7%) | 570(76.3%) | 1.0 | Reference | Reference |
Second stage C/S | |||||
Yes | 30(90.5%) | 3(9.1%) | 45.25 | 13.64–150.13 | <0.001 |
No | 158(18.1%) | 715(71.9%) | 1.0 | Reference | Reference |